查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
空間基因組學和轉錄組學市場 - 2018-2028 年全球行業規模、佔有率、趨勢、機會和預測，按技術、產品類型、按應用、最終用戶、地區和競爭細分
市場調查報告書
商品編碼
1326479

空間基因組學和轉錄組學市場 - 2018-2028 年全球行業規模、佔有率、趨勢、機會和預測，按技術、產品類型、按應用、最終用戶、地區和競爭細分

Spatial Genomics and Transcriptomics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented by Technique, By Product Type, By Application, By End User, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 111 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

預計空間基因組學和轉錄組學市場在預測期內將出現令人印象深刻的成長。這可以歸因於對早期診斷和治療的需求不斷成長以及慢性病治療創新產品的開發。此外，基於細胞的研究資金的增加以及癌症研究新型細胞測定的需求不斷成長是預測期內推動全球空間基因組學和轉錄組學市場成長的主要因素。 2020年，Cancer Transcriptome Atlas推出了基於NanoString Technologies的新產品，並推出了名為GeoMx Digital Spatial Profiler（DSP）平台的新平台，用於Illumina下一代測序（NGS）技術上的讀數。

對個性化醫療的需求不斷增加

個性化醫療是全球空間基因組學和轉錄組學市場成長的關鍵驅動力之一。個性化醫療涉及利用基因組資訊為個體患者量身定做治療方案，目的是改善治療結果並減少不良反應。空間基因組學和轉錄組學可以更全面地了解基因的組織和功能，從而更容易為患有複雜疾病的患者開發個性化治療。

慢性病患病率不斷上升

癌症、心血管疾病和糖尿病等慢性病的患病率不斷上升，是預測期內推動全球空間基因組學和轉錄組學市場成長的主要因素。空間基因組學和轉錄組學有助於慢性病的早期檢測、診斷和治療，從而改善患者的治療效果。空間基因組學和轉錄組學使研究人員能夠研究特定組織（例如癌細胞）中基因的組織和功能。這使得能夠識別與慢性疾病的發生和進展相關的基因和基因表達模式。通過了解這些疾病背後的分子機制，研究人員可以開發出更有針對性和更有效的新療法。空間基因組學和轉錄組學可用於監測患者對治療的反應，從而根據需要對治療進行個性化調整。這有助於改善治療結果並降低不良反應的風險。這導致研發投資增加，包括在藥物發現和開發中採用空間基因組學和轉錄組學。

研發投資不斷增加

研究與開發（R&D）是推動全球空間基因組學和轉錄組學市場成長的關鍵因素。技術進步、新產品開發和不斷增加的研發投資正在推動市場的成長。隨著空間基因組學和轉錄組學新應用的發現，對新的和改進的產品和技術的需求不斷成長。這正在推動空間基因組學和轉錄組學新儀器、軟體和耗材的開發。隨著公司尋求從競爭對手中脫穎而出並獲得市場佔有率，新產品和新技術的推出正在推動市場成長。

此外，研發投資對於空間基因組學和轉錄組學的持續發展至關重要。隨著該技術得到更廣泛的採用，對新的創新應用和新技術的開發的需求不斷成長，以進一步提高該技術的準確性和靈敏度。研發投資對於解決市場面臨的挑戰是必要的，例如儀器和耗材的高成本以及數據分析的複雜性。政府資助和私人研發投資正在推動全球空間基因組學和轉錄組學市場的成長。政府和私人投資者正在認知到該技術的潛力，並為研究提供資金，這正在加速新應用和技術的開發。

測序和微陣列技術的進步

測序和微陣列技術是推動全球空間基因組學和轉錄組學市場成長的關鍵因素。這兩種技術在使研究人員能夠研究特定組織中基因的組織和功能方面發揮著至關重要的作用。新一代測序 (NGS) 等測序技術可以對單個細胞或組織的 DNA 或 RNA 進行測序，從而提供轉錄組或基因組的高解析度視圖。這允許識別與特定組織、細胞類型或疾病相關的基因和基因表達模式。

測序技術在空間基因組學和轉錄組學中得到廣泛採用，以識別複雜組織（例如大腦、腫瘤微環境和免疫細胞）中的細胞類型和細胞相互作用。另一方面，微陣列技術可以同時檢測許多基因的基因表達模式。微陣列可用於研究單個細胞或組織中的基因表達，或在大規模實驗中用於識別與特定疾病相關的生物標記或基因特徵。

空間分辨微陣列技術，例如 Nanostring nCounter 系統，可以同時檢測單個細胞或小組織區域的基因表達。空間基因組學和轉錄組學中測序和微陣列技術的採用正在推動新應用和產品的開發，例如空間分辨轉錄組學和單細胞測序。隨著更多的研究人員和公司可以訪問和利用這些技術，這些技術的可用性正在推動市場的成長。

增加生物資訊學的採用

生物資訊學是推動全球空間基因組學和轉錄組學市場成長的關鍵因素。空間基因組學和轉錄組學產生大量數據，這些數據的分析和解釋需要先進的計算工具和算法。生物資訊學為空間基因組學和轉錄組學數據的分析和解釋提供了必要的工具和技術。生物資訊學工具使研究人員能夠識別特定組織中基因表達和基因組組織的模式，並了解基因和蛋白質之間的功能關係。這些工具還能夠將空間基因組學和轉錄組學數據與其他類型的基因組學和蛋白質組學數據整合，從而能夠更全面地了解基因功能和調控。

生物資訊學工具的可用性正在推動空間基因組學和轉錄組學新應用和產品的開發。公司正在開發軟體平台和分析工具，使研究人員能夠分析和可視化空間基因組學和轉錄組學數據，並將這些數據與其他類型的基因組和蛋白質組資料整合。生物資訊學工具的可用性正在推動市場的成長，因為更多的研究人員和公司可以訪問和利用該技術。開源生物資訊學工具和數據庫（例如艾倫腦圖譜）的發展正在推動市場的成長，因為這些工具使研究人員能夠訪問和分析來自各種來源的空間基因組學和轉錄組學數據。

近期發展

  • 10x Genomics Visium 空間基因表達解決方案：該解決方案於 2019 年推出，能夠對基因表達和組織形態進行原位高通量分析，使研究人員能夠了解細胞和組織的空間組織。
  • NanoString GeoMx 數位空間分析儀：該平台於 2018 年推出，可提供組織中 RNA 和蛋白質表達的高解析度空間分析，從而能夠表徵複雜的細胞環境和識別疾病生物標記。
  • Cartana 空間轉錄組學試劑盒：該試劑盒於 2020 年推出，能夠原位捕獲和分析 RNA 表達數據，使研究人員能夠研究複雜組織結構內的基因表達模式。
  • Akoya Biosciences Phenoptics 2.0：該成像平台於 2021 年推出，能夠對組織樣本進行多重分析，將空間分析與表型分析相結合，以提供對細胞功能的更全面的了解。
  • Fluidigm Advanta Spatial Transcriptomics：該技術於 2019 年推出，可以原位捕獲和分析 RNA 表達數據，提供有關組織中基因表達模式的高解析度空間資訊。

可用的客製化：

根據給定的市場數據，TechSci Research 可根據公司的具體需求提供客製化服務。該報告可以使用以下自定義選項：

公司資訊

  • 其他市場參與者（最多五個）的詳細分析和概況分析。

目錄

第 1 章：產品概述

  • 市場定義
  • 市場範圍
    • 涵蓋的市場
    • 考慮學習的年份
    • 主要市場細分

第 2 章：研究方法

  • 研究目的
  • 基線方法
  • 主要行業合作夥伴
  • 主要協會和二手資料來源
  • 預測方法
  • 數據三角測量和驗證
  • 假設和限制

第 3 章：執行摘要

  • 市場概況
  • 主要市場細分概述
  • 主要市場參與者概述
  • 重點地區/國家概況
  • 市場促進因素、挑戰、趨勢概述

第 4 章：客戶之聲

第 5 章：全球空間基因組學和轉錄組學市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按技術分類（空間轉錄組學與空間基因組學分析）
    • 按產品類型（儀器、消耗品、軟體）
    • 按應用（轉化研究與藥物發現和開發）
    • 按最終用戶（製藥和生物技術公司、契約研究組織、學術和研究機構）
    • 按地區（北美、歐洲、亞太地區、南美、中東和非洲）
    • 按公司分類 (2022)
  • 市場地圖
    • 按技術
    • 按產品類型
    • 按應用
    • 按最終用戶
    • 按地區

第 6 章：北美空間基因組學和轉錄組學市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按技術分類（空間轉錄組學與空間基因組學分析）
    • 按產品類型（儀器、消耗品、軟體）
    • 按應用（轉化研究與藥物發現和開發）
    • 按最終用戶（製藥和生物技術公司、契約研究組織、學術和研究機構）
    • 按國家/地區
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第 7 章：歐洲空間基因組學和轉錄組學市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按技術分類（空間轉錄組學與空間基因組學分析）
    • 按產品類型（儀器、消耗品、軟體）
    • 按應用（轉化研究與藥物發現和開發）
    • 按最終用戶（製藥和生物技術公司、契約研究組織、學術和研究機構）
    • 按國家/地區
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第 8 章：亞太空間基因組學和轉錄組學市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按技術分類（空間轉錄組學與空間基因組學分析）
    • 按產品類型（儀器、消耗品、軟體）
    • 按應用（轉化研究與藥物發現和開發）
    • 按最終用戶（製藥和生物技術公司、契約研究組織、學術和研究機構）
    • 按國家/地區
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳大利亞

第 9 章：南美空間基因組學和轉錄組學市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按技術分類（空間轉錄組學與空間基因組學分析）
    • 按產品類型（儀器、耗材、軟體）
    • 按應用（轉化研究與藥物發現和開發）
    • 按最終用戶（製藥和生物技術公司、契約研究組織、學術和研究機構）
    • 按國家/地區
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章：中東和非洲空間基因組學和轉錄組學市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按技術分類（空間轉錄組學與空間基因組學分析）
    • 按產品類型（儀器、消耗品、軟體）
    • 按應用（轉化研究與藥物發現和開發）
    • 按最終用戶（製藥和生物技術公司、契約研究組織、學術和研究機構）
    • 按國家/地區
  • MEA：國家分析
    • 南非空間基因組學和轉錄組學
    • 沙烏地阿拉伯空間基因組學和轉錄組學
    • 阿拉伯聯合大公國空間基因組學和轉錄組學

第 11 章：市場動態

  • 司機
    • 對實驗室自動化活動的需求不斷成長
    • 生物樣本庫擴大採用實驗室資訊學
    • 擴大引入技術先進的軟體服務
  • 挑戰
    • 缺乏實驗室資訊學整合標準
    • 嚴格的規定

第 12 章：市場趨勢與發展

  • 近期發展
  • 併購
  • 產品發布

第 13 章：全球空間基因組學和轉錄組學市場：SWOT 分析

第 14 章：波特的五力分析

  • 行業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 客戶的力量
  • 替代產品的威脅

第15章：競爭格局

  • 商業概覽
  • 產品供應
  • 最近的發展
  • 財務（據報導）
  • 主要人員
  • SWOT分析
    • 10X Genomics Inc.
    • Akoya Bioscience Ltd.
    • Biospyder Technologies Inc.
    • BioTechne Corporation.
    • Dovetail Genomics LLC.
    • Fluidigm Corporation.
    • Genomic Vision SA.
    • Illumina Inc.
    • Lunaphore Technologies SA.
    • Nanostring Technolgies Inc.

第 16 章：戰略建議

簡介目錄
Product Code: 15176

Spatial Genomics and Transcriptomics Market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the growing demand for early diagnosis and remedial treatment and the development of innovative products for the treatment of chronic diseases. Also, increasing funding for cell-based research and growing demand for novel cell assays for cancer research are the major factors for driving the growth of the Global Spatial Genomics and Transcriptomics Market during the forecast period. In 2020, Cancer Transcriptome Atlas launched a new product based on NanoString Technologies and launched a new platform called as GeoMx Digital Spatial Profiler (DSP) platform, which is used for readout on Illumina's next-generation sequencing (NGS) technology.

Increasing Demand for Personalized Medicine

Personalized medicine is one of the key drivers of the growth of Global Spatial Genomics and Transcriptomics Market. Personalized medicine involves the use of genomic information to tailor treatments to individual patients, with the aim of improving treatment outcomes and reducing adverse effects. Spatial genomics and transcriptomics provide a more comprehensive understanding of the organization and function of genes, making it easier to develop personalized treatments for patients with complex diseases.

Spatial genomics and transcriptomics can help to identify specific genes and their expression patterns that are associated with disease, allowing for more targeted and effective therapies. This can be particularly beneficial for patients with cancer, as spatial genomics and transcriptomics can help to identify genetic changes that lead to the development and progression of cancer. Spatial genomics and transcriptomics can be used to monitor the response of patients to treatment, allowing for personalized adjustments to be made to their therapy as needed. This can help to improve treatment outcomes and reduce the risk of adverse effects. The growing demand for personalized medicine is driving the adoption of spatial genomics and transcriptomics in the biotechnology and pharmaceutical industry, as well as in academic and research institutions. This is leading to the development of new applications for the technology, which is expected to further drive the growth of the global spatial genomics and transcriptomics market in the coming years.

Growing Prevalence of Chronic Diseases

The increasing prevalence of Chronic diseases, such as cancer, cardiovascular disease, and diabetes, is a major factor that will drive the growth of the Global Spatial Genomics and Transcriptomics Market during the forecast period. Spatial genomics and transcriptomics can help in the early detection, diagnosis, and treatment of chronic diseases, leading to better patient outcomes. Spatial genomics and transcriptomics enable researchers to study the organization and function of genes in specific tissues, such as cancer cells. This allows for the identification of genes and gene expression patterns that are associated with the development and progression of chronic diseases. By understanding the molecular mechanisms underlying these diseases, researchers can develop new treatments and therapies that are more targeted and effective. Spatial genomics and transcriptomics can be used to monitor the response of patients to treatment, allowing for personalized adjustments to be made to their therapy as needed. This can help to improve treatment outcomes and reduce the risk of adverse effects. This is leading to increased investment in research and development, including the adoption of spatial genomics and transcriptomics in drug discovery and development.

Rising Investment in Research & Development

Research & development (R&D) is a crucial factor in driving the growth of the Global Spatial Genomics and Transcriptomics Market. Advancements in technology, new product development, and increasing R&D investment are driving the growth of the market. As new applications of spatial genomics and transcriptomics are discovered, there is a growing need for new and improved products and technologies. This is driving the development of new instruments, software, and consumables for spatial genomics and transcriptomics. The introduction of new products and technologies is driving market growth as companies seek to differentiate themselves from competitors and gain market share.

In addition, R&D investment is critical to the continued development of spatial genomics and transcriptomics. As the technology becomes more widely adopted, there is a growing need for new and innovative applications and the development of new technologies that can further improve the accuracy and sensitivity of the technology. R&D investment is necessary to address the challenges facing the market, such as the high cost of instruments and consumables and the complexity of data analysis. Government funding and private investment in R&D are driving the growth of the global spatial genomics and transcriptomics market. Governments and private investors are recognizing the potential of the technology and are providing funding for research, which is accelerating the development of new applications and technologies.

Advancements in Sequencing and Microarray Technologies

Sequencing and microarray technologies are key factors driving the growth of the Global Spatial Genomics and Transcriptomics Market. Both technologies play a crucial role in enabling researchers to study the organization and function of genes in specific tissues. Sequencing technologies, such as next-generation sequencing (NGS), enable the sequencing of DNA or RNA from individual cells or tissues, providing a high-resolution view of the transcriptome or genome. This allows for the identification of genes and gene expression patterns that are associated with specific tissues, cell types, or diseases.

Sequencing technologies are being widely adopted in spatial genomics and transcriptomics to enable the identification of cell types and cell interactions in complex tissues, such as the brain, tumor microenvironments, and immune cells. Microarray technologies, on the other hand, enable the detection of gene expression patterns in many genes simultaneously. Microarrays can be used to study gene expression in individual cells or tissues or in large-scale experiments to identify biomarkers or gene signatures associated with specific diseases.

Spatially resolved microarray technologies, such as the Nanostring nCounter system, allow simultaneous detection of gene expression in individual cells or small tissue regions. The adoption of sequencing and microarray technologies in Spatial Genomics and Transcriptomics is driving the development of new applications and products, such as spatially resolved transcriptomics and single-cell sequencing. The availability of these technologies is driving the growth of the market as more researchers and companies can access and utilize the technology.

Increasing Adoption of Bioinformatics

Bioinformatics is a crucial factor driving the growth of the Global Spatial Genomics and Transcriptomics Market. Spatial genomics and transcriptomics generate large volumes of data, and the analysis and interpretation of this data require advanced computational tools and algorithms. Bioinformatics provides the necessary tools and techniques for the analysis and interpretation of spatial genomics and transcriptomics data. Bioinformatics tools enable researchers to identify patterns in gene expression and genomic organization in specific tissues and to understand the functional relationships between genes and proteins. These tools also enable the integration of spatial genomics and transcriptomics data with other types of genomic and proteomic data, enabling a more comprehensive understanding of gene function and regulation.

The availability of bioinformatics tools is driving the development of new applications and products in spatial genomics and transcriptomics. Companies are developing software platforms and analysis tools that enable researchers to analyze and visualize spatial genomics and transcriptomics data and integrate this data with other types of genomic and proteomic data. The availability of bioinformatics tools is driving the growth of the market, as more researchers and companies can access and utilize the technology. The development of open-source bioinformatics tools and databases, such as the Allen Brain Atlas, is driving the growth of the market, as these tools enable researchers to access and analyze spatial genomics and transcriptomics data from a variety of sources.

Recent Development

  • 10x Genomics Visium Spatial Gene Expression Solution: Launched in 2019, this solution enables the high-throughput analysis of gene expression and tissue morphology in situ, allowing researchers to understand the spatial organization of cells and tissues.
  • NanoString GeoMx Digital Spatial Profiler: Launched in 2018, this platform provides high-resolution spatial profiling of RNA and protein expression in tissues, enabling the characterization of complex cellular environments and the identification of disease biomarkers.
  • Cartana Spatial Transcriptomics Kit: Launched in 2020, this kit enables the capture and analysis of RNA expression data in situ, allowing researchers to study gene expression patterns within complex tissue structures.
  • Akoya Biosciences Phenoptics 2.0: Launched in 2021, this imaging platform enables the multiplexed analysis of tissue samples, combining spatial profiling with phenotypic analysis to provide a more comprehensive understanding of cellular function.
  • Fluidigm Advanta Spatial Transcriptomics: Launched in 2019, this technology allows for the capture and analysis of RNA expression data in situ, providing high-resolution spatial information about gene expression patterns in tissues.

Market Segmentation

Global Spatial Genomics and Transcriptomics market can be segmented by technique, product type, application, end-user, and region. Based on the technique, the market can be divided into spatial transcriptomics and spatial genomics analysis. Based on product type, the market can be segmented into instruments, consumables, and software. Based on application, the market can be divided into Translational Research and Drug discovery & development. Based on end-user, the market can be differentiated into pharmaceutical & biotechnology companies, contract research organizations, and academic & research institutes.

Market Players

10X Genomics Inc., Akoya Bioscience Ltd., Biospyder Technologies Inc., BioTechne Corporation., Dovetail Genomics LLC., Fluidigm Corporation., Genomic Vision SA., Illumina Inc., Lunaphore Technologies SA., Nanostring Technolgies Inc. are some of the leading players operating in the Global Spatial Genomics and Transcriptomics Market.

Report Scope:

In this report, Global Spatial Genomics and Transcriptomics market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Spatial Genomics and Transcriptomics Market, By Technique:

  • Spatial Transcriptomics
  • Spatial Genomics Analysis

Spatial Genomics and Transcriptomics Market, By Product Type:

  • Instruments
  • Consumables
  • Software

Spatial Genomics and Transcriptomics Market, By Application:

  • Translational Research
  • Drug discovery & development

Spatial Genomics and Transcriptomics Market, By End User:

  • Pharmaceutical & Biotechnology companies
  • Contract Research Organizations
  • Academic & Research Institutes

Spatial Genomics and Transcriptomics Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Spatial Genomics and Transcriptomics Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Spatial Genomics and Transcriptomics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Technique (Spatial Transcriptomics v/s Spatial Genomics Analysis)
    • 5.2.2. By Product Type (Instruments, Consumables, Software)
    • 5.2.3. By Application (Translational Research v/s Drug discovery & development)
    • 5.2.4. By End User (Pharmaceutical & Biotechnology companies, Contract Research Organizations, Academic & Research Institutes)
    • 5.2.5. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
    • 5.2.6. By Company (2022)
  • 5.3. Market Map
    • 5.3.1 By Technique
    • 5.3.2 By Product Type
    • 5.3.3 By Application
    • 5.3.4 By End User
    • 5.3.5 By Region

6. North America Spatial Genomics and Transcriptomics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Technique (Spatial Transcriptomics v/s Spatial Genomics Analysis)
    • 6.2.2. By Product Type (Instruments, Consumables, Software)
    • 6.2.3. By Application (Translational Research v/s Drug discovery & development)
    • 6.2.4. By End User (Pharmaceutical & Biotechnology companies, Contract Research Organizations, Academic & Research Institutes)
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Spatial Genomics and Transcriptomics Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Technique
        • 6.3.1.2.2. By Product Type
        • 6.3.1.2.3. By Application
        • 6.3.1.2.4. By End User
    • 6.3.2. Canada Spatial Genomics and Transcriptomics Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Technique
        • 6.3.2.2.2. By Product Type
        • 6.3.2.2.3. By Application
        • 6.3.2.2.4. By End User
    • 6.3.3. Mexico Spatial Genomics and Transcriptomics Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Technique
        • 6.3.3.2.2. By Product Type
        • 6.3.3.2.3. By Application
        • 6.3.3.2.4. By End User

7. Europe Spatial Genomics and Transcriptomics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Technique (Spatial Transcriptomics v/s Spatial Genomics Analysis)
    • 7.2.2. By Product Type (Instruments, Consumables, Software)
    • 7.2.3. By Application (Translational Research v/s Drug discovery & development)
    • 7.2.4. By End User (Pharmaceutical & Biotechnology companies, Contract Research Organizations, Academic & Research Institutes)
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Spatial Genomics and Transcriptomics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Technique
        • 7.3.1.2.2. By Product Type
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End User
    • 7.3.2. Germany Spatial Genomics and Transcriptomics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Technique
        • 7.3.2.2.2. By Product Type
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End User
    • 7.3.3. United Kingdom Spatial Genomics and Transcriptomics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Technique
        • 7.3.3.2.2. By Product Type
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End User
    • 7.3.4. Italy Spatial Genomics and Transcriptomics Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Technique
        • 7.3.4.2.2. By Product Type
        • 7.3.4.2.3. By Application
        • 7.3.4.2.4. By End User
    • 7.3.5. Spain Spatial Genomics and Transcriptomics Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Technique
        • 7.3.5.2.2. By Product Type
        • 7.3.5.2.3. By Application
        • 7.3.5.2.4. By End User

8. Asia-Pacific Spatial Genomics and Transcriptomics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Technique (Spatial Transcriptomics v/s Spatial Genomics Analysis)
    • 8.2.2. By Product Type (Instruments, Consumables, Software)
    • 8.2.3. By Application (Translational Research v/s Drug discovery & development)
    • 8.2.4. By End User (Pharmaceutical & Biotechnology companies, Contract Research Organizations, Academic & Research Institutes)
    • 8.2.5. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Spatial Genomics and Transcriptomics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Technique
        • 8.3.1.2.2. By Product Type
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End User
    • 8.3.2. India Spatial Genomics and Transcriptomics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Technique
        • 8.3.2.2.2. By Product Type
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End User
    • 8.3.3. Japan Spatial Genomics and Transcriptomics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Technique
        • 8.3.3.2.2. By Product Type
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End User
    • 8.3.4. South Korea Spatial Genomics and Transcriptomics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Technique
        • 8.3.4.2.2. By Product Type
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By End User
    • 8.3.5. Australia Spatial Genomics and Transcriptomics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Technique
        • 8.3.5.2.2. By Product Type
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By End User

9. South America Spatial Genomics and Transcriptomics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Technique (Spatial Transcriptomics v/s Spatial Genomics Analysis)
    • 9.2.2. By Product Type (Instruments, Consumables, Software)
    • 9.2.3. By Application (Translational Research v/s Drug discovery & development)
    • 9.2.4. By End User (Pharmaceutical & Biotechnology companies, Contract Research Organizations, Academic & Research Institutes)
    • 9.2.5. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Spatial Genomics and Transcriptomics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Technique
        • 9.3.1.2.2. By Product Type
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End User
    • 9.3.2. Argentina Spatial Genomics and Transcriptomics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Technique
        • 9.3.2.2.2. By Product Type
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End User
    • 9.3.3. Colombia Spatial Genomics and Transcriptomics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Technique
        • 9.3.3.2.2. By Product Type
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End User

10. Middle East and Africa Spatial Genomics and Transcriptomics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Technique (Spatial Transcriptomics v/s Spatial Genomics Analysis)
    • 10.2.2. By Product Type (Instruments, Consumables, Software)
    • 10.2.3. By Application (Translational Research v/s Drug discovery & development)
    • 10.2.4. By End User (Pharmaceutical & Biotechnology companies, Contract Research Organizations, Academic & Research Institutes)
    • 10.2.5. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Spatial Genomics and Transcriptomics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Technique
        • 10.3.1.2.2. By Product Type
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By End User
    • 10.3.2. Saudi Arabia Spatial Genomics and Transcriptomics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Technique
        • 10.3.2.2.2. By Product Type
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By End User
    • 10.3.3. UAE Spatial Genomics and Transcriptomics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Technique
        • 10.3.3.2.2. By Product Type
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By End User

11. Market Dynamics

  • 11.1. Drivers
    • 11.1.1 Growing demand for lab automation activities
    • 11.1.2 Growing adoption of lab informatics by biobanks
    • 11.1.3 Growing introduction of technologically advanced software services
  • 11.2. Challenges
    • 11.2.1 Lack of integration standards for laboratory informatics
    • 11.2.2 Stringent Regulations

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Spatial Genomics and Transcriptomics Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Product Offerings
  • 15.3. Recent Developments
  • 15.4. Financials (As Reported)
  • 15.5. Key Personnel
  • 15.6. SWOT Analysis
    • 15.6.1 10X Genomics Inc.
    • 15.6.2 Akoya Bioscience Ltd.
    • 15.6.3 Biospyder Technologies Inc.
    • 15.6.4 BioTechne Corporation.
    • 15.6.5 Dovetail Genomics LLC.
    • 15.6.6 Fluidigm Corporation.
    • 15.6.7 Genomic Vision SA.
    • 15.6.8 Illumina Inc.
    • 15.6.9 Lunaphore Technologies SA.
    • 15.6.10 Nanostring Technolgies Inc.

16. Strategic Recommendations